LFCR Q4 2019 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$153M+8.3% YoY

Gross Profit

$26M17.2% margin

Operating Income

$2M1.6% margin

Net Income

-$262,000-0.2% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

-1.9%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$519M

Total Liabilities

$249M

Stockholders' Equity

$270M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$153M	$141M	+8.3%
Gross Profit	$26M	$25M	+5.7%
Operating Income	$2M	$8M	-69.3%
Net Income	-$262,000	$6M	-104.3%